Global Injection Pen Market : Industry Size, Share, Analysis, Trend & Future Planning 2022
Bharat Book Bureau Provides the Trending Market Research Report on“Global Injection Pen Market, Forecast to 2022” underLife Sciences category. The report provides information on industry overview, market size, latest developments, industry trends,Key Players, global presence, and their future prospects.
Injection Pen Market is projected to grow at aCAGR of 6.0% during the forecast period
The global injection pen market is expected to reachUSD 41.38 billion by 2022 from an estimated USD 30.97 billion in 2017, at a CAGR of 6.0% during the forecast period. Growing prevalence of chronic diseases across the globe, increasing number of regulatory approvals, and favorable reimbursements are expected to drive the growth of the injection pen market. However, preference for alternative drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of this market to a certain extent.
By type, the disposable injection pens segment is expected to grow at the highest rate during the forecast period (2017–2022).
Based on type, the market is segmented into disposable and reusable injection pens. The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the benefits that these pens offer, such as portability, ease of use, and a lower possibility of infection.
Request a free sample copy ofInjection Pen MarketReport @ https://www.bharatbook.com/request-sample/735198
By therapy, the diabetes segment is expected to grow at the highest CAGR during the study period.
Based on therapy, the global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies. The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of the segment can be primarily attributed to the large diabetic population and favorable reimbursements for diabetic treatments in developed countries. The diabetes segment is further segmented into Insulin and GLP-1.
The North American injection pen market is expected to grow at the highest CAGR during the forecast period
North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to the rising prevalence of diabetes in the US and Canada, a favorable reimbursement scenario, and the increasing number of awareness programs in that region.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–50%, Tier 2–30% and Tier 3–20%
- By Designation – C-level–30%, Director Level–48%, Others–22%
- By Region – North America–48%, Europe–20%, Asia Pacific–25%, Row–7%
The key players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).
To browse full research report with TOC, click the link below :
https://www.bharatbook.com/medical-devices-market-research-reports-735198/injection-pen-disposable.html
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email:poonam@bharatbook.com
Website:www.bharatbook.com
Follow us on: Twitter, Facebook, LinkedIn, Google Plus